Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LEO 19123 cream vehicle
- Development stage
- Unknown
- Lead developer
- LEO Pharma
- Administration
- Topical
01
Overview
The LEO 19123 cream vehicle is the inactive topical formulation used as a placebo control in clinical trials conducted by LEO Pharma for the treatment of psoriasis vulgaris. It was specifically utilized in Phase 2 split-body design studies to compare the efficacy and safety of LEO 19123 (a combination of calcipotriol and LEO 80122) against the vehicle alone and Dovonex (calcipotriol) cream. The vehicle consists of the cream base without the active pharmaceutical ingredients, serving to isolate the therapeutic effects of the active compounds from any potential moisturizing or occlusive effects of the formulation itself.
- Other names
- LEO 19123 vehicleLEO19123 vehicleLEO-19123 vehicle
Beyond the preview
Go deeper on LEO 19123 cream vehicle.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LEO 19123 cream vehicle.